Lymphoma
Lymphoma
We’re here for you. Call us at 844-346-7222 or
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
59
Clinical Trials
Lymphoma
N/A
Enrolling
nct/study# NCT06500273 / ALLO-501A-202
A randomized, open-label study evaluating the efficacy and safety of cemacabtagene ansegedleucel in participants with minimal residual disease after response to first line therapy for large B-cell lymphoma ALPHA3)
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / BURKITT-LYMPHOMA
Outcomes among Adult Recipients of CAR T-Cell Therapeutics for Burkitt and Burkitt-like Lymphoma
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / 2017-0341
Outcomes of Patients with Relapsed/Refractory Hodgkin Lymphoma Treated with PD-1 Inhibitors Outside of Clinical Trials
Learn More
Lymphoma
N/A
Enrolling
Lymphoma
N/A
Enrolling
nct/study# N/A / 2018-0158
Outcomes of Patients with Newly Diagnosed Peripheral T-cell Lymphoma Treated with Aggressive Chemotherapy, including Cutaneous Gamma-Delta T cell Lymphoma
Learn More
Lymphoma
Phase I
Enrolling
nct/study# NCT04637763 / CB10A
A Phase 1, Multicenter, Open-Label Study of CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy in Patients With Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.